| Taylor Gard Fletcher, MD | |
|
1000 Johnson Fy Rd Ne, Atlanta, GA 30342-1611 | |
| (951) 233-1900 | |
| Not Available |
| Full Name | Taylor Gard Fletcher |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 46 Years |
| Location | 1000 Johnson Fy Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205889680 | NPI | - | NPPES |
| 121312 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G49762 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northside Emergency Associates, P.c. | 9335135144 | 29 |
News Archive
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
Antiva Biosciences, Inc. (formerly Hera Therapeutics), a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $16 million in a Series B financing, its first institutional round.
Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease.
Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a new study, however, researchers from Federal University of Santa Catarina provided Brazilian breast cancer patients with nutrition education and found it could benefit patients and may help prevent reoccurrence of the cancer.
› Verified 3 days ago
| Entity Name | Northside Emergency Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285686303 PECOS PAC ID: 9335135144 Enrollment ID: O20040426000165 |
News Archive
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
Antiva Biosciences, Inc. (formerly Hera Therapeutics), a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $16 million in a Series B financing, its first institutional round.
Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease.
Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a new study, however, researchers from Federal University of Santa Catarina provided Brazilian breast cancer patients with nutrition education and found it could benefit patients and may help prevent reoccurrence of the cancer.
› Verified 3 days ago
| Entity Name | Gwinnett Emergency Specialists Observation Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720373129 PECOS PAC ID: 7618140955 Enrollment ID: O20111101000364 |
News Archive
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
Antiva Biosciences, Inc. (formerly Hera Therapeutics), a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $16 million in a Series B financing, its first institutional round.
Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease.
Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a new study, however, researchers from Federal University of Santa Catarina provided Brazilian breast cancer patients with nutrition education and found it could benefit patients and may help prevent reoccurrence of the cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Taylor Gard Fletcher, MD 4532 Collins Ave, Sandy Springs, GA 30342-4125 Ph: (951) 233-1900 | Taylor Gard Fletcher, MD 1000 Johnson Fy Rd Ne, Atlanta, GA 30342-1611 Ph: (951) 233-1900 |
News Archive
A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.
Antiva Biosciences, Inc. (formerly Hera Therapeutics), a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $16 million in a Series B financing, its first institutional round.
Turning the tables, Katherine Borden at the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) has evoked Star Trek's Borg in her fight against the disease.
Breast cancer is the most frequent cause of death among women worldwide, and five-year survival rates are just 58.4% in Brazil, lower than in many other regions. In a new study, however, researchers from Federal University of Santa Catarina provided Brazilian breast cancer patients with nutrition education and found it could benefit patients and may help prevent reoccurrence of the cancer.
› Verified 3 days ago
Dr. Benjamin Aaron Levy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5665 New Northside Dr Nw, Suite 200, Atlanta, GA 30328 Phone: 770-874-5400 | |
Essi I Peers, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5665 New Northside Dr Ste 200, Atlanta, GA 30328 Phone: 770-874-5400 | |
Prince N Martin, Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5665 Peachtree Dunwoody Rd, Atlanta, GA 30342 Phone: 678-843-7001 | |
Melissa H White, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Jesse Hill Jr Dr Se, Atlanta, GA 30303 Phone: 404-616-4307 Fax: 404-616-8022 | |
John H Lloyd, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1358 Middlesex Ave Ne, Atlanta, GA 30306 Phone: 404-944-7563 | |
Dr. Vida M. Reklaitis, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-851-6936 Fax: 404-851-6024 | |
Dr. Steven M Joyce, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2292 Peachtree Rd., Nw, Atlanta, GA 30309 Phone: 801-558-7791 |